Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Na+/K+-ATPase inhibitors disclosed by Sigma-Tau

May 24, 1996

Medco, Fujisawa to codevelop and comarket adenosine for CABG and AMI

May 24, 1996

Transdermal scopolamine studied in hypertensive patients

May 24, 1996

Update on fenoldopam regulatory submission

May 24, 1996

Progress on endothelin antagonists at Texas Biotechnology

May 24, 1996

More angiotensin II antagonists from Japanese companies

May 24, 1996

ADIR claims compounds for venous insufficiency

May 24, 1996

ADIR claims imidazoline I1 receptor ligands for hypertension

May 24, 1996

Baxter will develop graft system developed by Australian investigators

May 24, 1996

Lilly reports agents for septic shock

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...